Processa Pharmaceuticals, Inc. current report, 26 September 2014

SEC Filing Summary: Heatwurx, Inc. (Form 8-K)

Business Context and Reporting Period

This Form 8-K was filed by Heatwurx, Inc. on September 26, 2014. The registrant is incorporated in Delaware and maintains its principal executive offices in Gardena, California. The filing serves as a Regulation FD disclosure regarding a strategic business development.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain audited financial statements or quarterly results.

Material Changes and Events

  • Strategic Agreement: On September 26, 2014, the Company issued a press release announcing it entered into a Letter of Intent (LOI) to distribute its patented asphalt and restoration repair technology in China.
  • Regulatory Status: The information contained in this report and the attached press release (Exhibit 99.1) is furnished but not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

Guidance, Outlook, and Risks

The filing does not contain forward-looking financial guidance, management commentary on future performance, or a discussion of specific risks and contingencies beyond the standard disclaimer regarding the non-filed status of the press release. The primary focus is the execution of the LOI for international distribution.

Investor Verification Checklist

  • Verify the terms and binding nature of the Letter of Intent (LOI) with the Chinese distributor.
  • Confirm the status of the patented asphalt and restoration repair technology in the Chinese market.
  • Review the attached press release (Exhibit 99.1) for specific details on the partnership structure.
  • Note that this filing does not constitute a formal financial update or earnings report.